Sanford Burnham Prebys Medical Discovery Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sanford Burnham Prebys Medical Discovery Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9350
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sanford Burnham Prebys Medical Discovery Institute (SBP) is a non-profit public benefit institute that offers medical research services. The institute offers research programs in the field of tumor initiation and maintenance, cancer metabolism and signaling networks, tumor microenvironment and cancer immunology, degenerative diseases, immunity and pathogenesis, human genetics development, aging and regeneration, bioinformatics and structural biology, cardiovascular metabolism, integrative metabolism, and genomic control of metabolism. It offers stem cell research and drug discovery technologies. SBP also offers educational services such as postdoctoral training, graduate school and international services. The institute’s technology centers include conrad prebys center for chemical genomics, stem cell research center and translational research institute, among others. It operates through its offices in La Jolla and Orlando, the US. SBP is headquartered in La Jolla, California, the US.

Sanford Burnham Prebys Medical Discovery Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Takeda Pharma Enters into Agreement with Sanford-Burnham 11
Eli Lilly Enters into Research Agreement with Sanford Burnham 12
Sanford Burnham Enters into Co-Development Agreement with Daiichi Sankyo 13
Sanford-Burnham Medical Research Institute Enters Into Research Agreement With Pfizer 14
Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 15
Sanford Burnham Enters into Agreement With 60 Degrees Pharma 16
Sanford-Burnham And Florida Hospital Extend Research Agreement With Takeda 17
Sanford-Burnham Medical Enters Into Agreement With Intrexon For Stem Cell Research 19
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 20
Licensing Agreements 22
Tarrex Biopharma Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 22
Clementia Pharma Enters Into License Agreement With Sanford Burnham Prebys Medical 23
DrugCendR Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 24
Sanford Burnham Prebys Medical Discovery Institute – Key Competitors 25
Sanford Burnham Prebys Medical Discovery Institute – Key Employees 26
Sanford Burnham Prebys Medical Discovery Institute – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Government and Public Interest 28
Sep 26, 2017: SBP scientist receives $10.8 million grant to advance potential drug for substance abuse 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Key Facts 2
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanford Burnham Prebys Medical Discovery Institute, Deals By Therapy Area, 2012 to YTD 2018 8
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Takeda Pharma Enters into Agreement with Sanford-Burnham 11
Eli Lilly Enters into Research Agreement with Sanford Burnham 12
Sanford Burnham Enters into Co-Development Agreement with Daiichi Sankyo 13
Sanford-Burnham Medical Research Institute Enters Into Research Agreement With Pfizer 14
Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 15
Sanford Burnham Enters into Agreement With 60 Degrees Pharma 16
Sanford-Burnham And Florida Hospital Extend Research Agreement With Takeda 17
Sanford-Burnham Medical Enters Into Agreement With Intrexon For Stem Cell Research 19
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 20
Tarrex Biopharma Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 22
Clementia Pharma Enters Into License Agreement With Sanford Burnham Prebys Medical 23
DrugCendR Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 24
Sanford Burnham Prebys Medical Discovery Institute, Key Competitors 25
Sanford Burnham Prebys Medical Discovery Institute, Key Employees 26
Sanford Burnham Prebys Medical Discovery Institute, Other Locations 27

List of Figures
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Sanford Burnham Prebys Medical Discovery Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SQI Diagnostics Inc (SQD):企業の製品パイプライン分析2018
    Summary SQI Diagnostics Inc (SQI Diagnostics) is a diagnostic company that offers in vitro diagnostic and pharmaceutical research products. The company’s products comprise sqidworks, sqidlite and sqid-X. Its sqidworks system is used in labs. SQI Diagnostic’s sqidlite is a practical benchtop system. …
  • Metabolon Inc-医療機器分野:企業M&A・提携分析
    Summary Metabolon Inc (Metabolon) is a health technology company that develops clinical diagnostic tests for healthcare markets. The company’s products include non-alcoholic steatohepatitis test, GFR test, quantose IGT test, prostarix and prostarix plus tests, among others. Its quantose IR test is a …
  • PFB Corp (PFB):企業の財務・戦略的SWOT分析
    Summary PFB Corp (PFB) is a diversified company. The company manufactures and distributes insulating building products and technologies. The company provides EPS product solutions such as insulspan structural insulating panel systems, rating system, insulated concrete forming system, timber framing …
  • BioTime Inc (BTX):医療機器:M&Aディール及び事業提携情報
    Summary BioTime Inc (BioTime) is a clinical-stage biotechnology company. It focuses on developing cures or treatments based on its core proprietary technology platforms for cell replacement and cell/drug delivery.The company's aesthetics products under development include Renevia , a potential treat …
  • Geistlich Pharma AG:企業の戦略的SWOT分析
    Geistlich Pharma AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Advanced Proteome Therapeutics Corp (APC)-製薬・医療分野:企業M&A・提携分析
    Summary Advanced Proteome Therapeutics Corporation (APC) is a biopharmaceutical company that focuses on the development of anticancer therapeutics that capitalizes on the properties of a natural human protein. It creates, develops and commercializes novel therapies. The company is advancing a site-s …
  • SMCP S.A.S (SMCP):企業の財務・戦略的SWOT分析
    SMCP S.A.S (SMCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ZoomMed Inc (ZMD)-医療機器分野:企業M&A・提携分析
    Summary ZoomMed Inc (ZoomMed) is a technical service provider that offers web solutions for medical sectors. The company’s product includes ZoomMed Network, ZRx Prescriber, PraxisLab, and EvPsych. It builds and operates a clinical information exchange platform between physicians and specialists, pat …
  • Perenco Holdings:企業の戦略的SWOT分析
    Perenco Holdings - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Camlin Fine Sciences Ltd:企業の戦略・SWOT・財務情報
    Camlin Fine Sciences Ltd - Strategy, SWOT and Corporate Finance Report Summary Camlin Fine Sciences Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Camden Property Trust:企業の戦略・SWOT・財務情報
    Camden Property Trust - Strategy, SWOT and Corporate Finance Report Summary Camden Property Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Premier Biomedical Inc (BIEI):製薬・医療:M&Aディール及び事業提携情報
    Summary Premier Biomedical Inc (Premier Biomedical) is a drug development company that develops medications for debilitating and fatal illnesses. The company offers Feldetrex, a drug candidate used for the treatment of multiple sclerosis, fibromyalgia, blood sepsis and viremia, and cancer. It develo …
  • Norwegian Energy Company ASA (NOR):企業の財務・戦略的SWOT分析
    Summary Norwegian Energy Company ASA (Noreco) is an upstream oil and gas company which carries out exploration, production and recovery of hydrocarbon resources. The company focuses on the development of oil and gas reserves; reservoir management and drilling activities; and acquisition of Shell’s u …
  • Larsen & Toubro Infotech Ltd (LTI):企業の財務・戦略的SWOT分析
    Larsen & Toubro Infotech Ltd (LTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Grasim Industries Limited:企業の戦略・SWOT・財務情報
    Grasim Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Grasim Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Immunovia AB (IMMNOV):企業の財務・戦略的SWOT分析
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • Alstom SA (ALO):電力:M&Aディール及び事業提携情報
    Summary Alstom SA (Alstom) is a marketer and developer of transport systems. The company offers a wide range of solutions ranging from high-speed trains to metros and tramways including customized services such as maintenance and modernization, and infrastructure up to signaling solutions. It design …
  • Angle Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers …
  • Frontera Energy Corp (FEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Frontera Energy Corp (Frontera), formerly Pacific Exploration & Production Corporation, is an upstream energy company. It carries out exploration, development and production of natural gas and crude oil. The company’s major assets include heavy oilfields of Quifa SW, Jaspe, Cajua, Quifa Nort …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆